FDA Commissioner Marty Makary resigns
Digest more
The head of the Food and Drug Administration, Dr. Marty Makary, is resigning after a rocky tenure that drew months of complaints from health industry executives, anti-abortion activists, vaping lobbyists and other allies of President Donald Trump.
The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major milestone for patients.
Marty Makary's expected exit is the latest shake-up at the Department of Health and Human Services, with some officials selected by Health Secretary Robert F. Kennedy Jr. being swapped out for more conventional choices.
The widely covered impending ouster of FDA Commissioner Marty Makary not long after the exit of controversial biologics head Vinay Prasad highlights the severe turnover rates at the highest rungs of leadership at the health department.
FDA Commissioner Marty Makary resigns after clashes over the abortion drug mifepristone and mounting pro-life group frustrations.
CBS News medical correspondent Dr. Céline Gounder breaks down the results. Federal health officials posted a warning about misleading statements by biotech billionaire Dr. Patrick Soon-Shiong about his company's bladder cancer drug Anktiva.
Food and Drug Administration Commissioner Marty Makary is resigning from his role, according to an administration source familiar with the matter. Kyle Diamantas, t
The Food and Drug Administration on Friday issued a new guidance document that outlines the agency’s current approach for electronic nicotine delivery systems (ENDS) and nicotine pouch products that do not have premarket authorization.